POAI Predictive Oncology Inc

Price (delayed)

$5.48

Market cap

$18.6M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$119.4

Enterprise value

$20.31M

?
Relative Growth: Rel. Growth: 24
Relative Strength: Rel. Strength: 2
Relative Valuation: Rel. Valuation: 13
Relative Profitability: Rel. Profitability: 5

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data ...

Highlights
Predictive Oncology's gross margin has surged by 87% YoY
POAI's revenue has soared by 84% YoY
The EPS has plunged by 161% YoY
Predictive Oncology's quick ratio has shrunk by 100% QoQ and by 100% YoY

Key stats

What are the main financial stats of POAI

POAI stock price

How has the Predictive Oncology stock price performed over time
Intraday
0.92%
1 week
-1.44%
1 month
-15.43%
1 year
-51.29%
YTD
-55.45%
QTD
-61.46%

Financial performance

How have Predictive Oncology's revenue and profit performed over time
Revenue
$728,195
Gross profit
$365,874
Operating income
-$10.36M
Net income
-$84.33M
Gross margin
50.2%
Net margin
-11,581.3%
Predictive Oncology's gross margin has surged by 87% YoY
POAI's revenue has soared by 84% YoY
POAI's operating margin is up by 50% year-on-year but it is down by 12% since the previous quarter
POAI's operating income is down by 12% QoQ but it is up by 8% YoY

Price vs fundamentals

How does POAI's price correlate with its fundamentals

Growth

What is Predictive Oncology's growth rate over time

Valuation

What is Predictive Oncology stock price valuation
P/E
N/A
P/B
N/A
P/S
5.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
27.89
The EPS has plunged by 161% YoY
POAI's revenue has soared by 84% YoY
The P/S is 73% lower than the 5-year quarterly average of 20.2 and 47% lower than the last 4 quarters average of 10.2

Efficiency

How efficient is Predictive Oncology business performance

Dividends

What is POAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for POAI.

Financial health

How did Predictive Oncology financials performed over time
The company's total assets is 96% lower than its total liabilities
Predictive Oncology's quick ratio has shrunk by 100% QoQ and by 100% YoY
The current ratio has dropped by 99% year-on-year and by 97% since the previous quarter
The company's debt is 102% higher than its equity
The debt to equity has plunged by 102% YoY but it has soared by 98% from the previous quarter
The company's debt fell by 21% YoY and by 10% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.